Protein structure-based design of potent orally bioavailable, nonpeptide inhibitors of human immunodeficiency virus protease.
- 11 April 1995
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 92 (8) , 3298-3302
- https://doi.org/10.1073/pnas.92.8.3298
Abstract
A class of potent nonpeptidic inhibitors of human immunodeficiency virus protease has been designed by using the three-dimensional structure of the enzyme as a guide. By employing iterative protein cocrystal structure analysis, design, and synthesis the binding affinity of the lead compound was incrementally improved by over four orders of magnitude. An inversion in inhibitor binding mode was observed crystallographically, providing information critical for subsequent design and highlighting the utility of structural feedback in inhibitor optimization. These inhibitors are selective for the viral protease enzyme, possess good antiviral activity, and are orally available in three species.Keywords
This publication has 15 references indexed in Scilit:
- De Novo Design of Enzyme Inhibitors by Monte Carlo Ligand GenerationJournal of Medicinal Chemistry, 1995
- Structure-Based Design of HIV Protease Inhibitors: 4-Hydroxycoumarins and 4-Hydroxy-2-pyrones as Non-peptidic InhibitorsJournal of Medicinal Chemistry, 1994
- Rational Design of Potent, Bioavailable, Nonpeptide Cyclic Ureas as HIV Protease InhibitorsScience, 1994
- Challenges in the therapy of HIV infectionTrends in Pharmacological Sciences, 1993
- Symmetry-based inhibitors of HIV protease. Structure-activity studies of acylated 2,4-diamino-1,5-diphenyl-3-hydroxypentane and 2,5-diamino-1,6-diphenylhexane-3,4-diolJournal of Medicinal Chemistry, 1993
- Novel binding mode of highly potent HIV-proteinase inhibitors incorporating the (R)-hydroxyethylamine isostereJournal of Medicinal Chemistry, 1991
- Rational Design of Peptide-Based HIV Proteinase InhibitorsScience, 1990
- High-level expression of self-processed HIV-1 protease in Escherichia coli using a synthetic geneBiochemical and Biophysical Research Communications, 1989
- Quantitative infectivity assay for HIV-1 and -2Nature, 1988
- Crystallographic R Factor Refinement by Molecular DynamicsScience, 1987